Abstract:Human immunodeficiency virus (HIV-1 or simply HIV) induces a persistent infection, which in the absence of treatment leads to AIDS and death in almost all infected individuals. HIV infection elicits a vigorous immune response starting about 2-3 weeks post infection that can lower the amount of virus in the body, but which cannot eradicate the virus. How HIV establishes a chronic infection in the face of a strong immune response remains poorly understood. It has been shown that HIV is able to rapidly change its proteins via mutation to evade recognition by virus-specific cytotoxic T lymphocytes (CTLs). Typically, an HIV-infected patient will generate 4-12 CTL responses specific for parts of viral proteins called epitopes. Such CTL responses lead to strong selective pressure to change the viral sequences encoding these epitopes so as to avoid CTL recognition. Here we review experimental data on HIV evolution in response to CTL pressure, mathematical models developed to explain this evolution, and highlight problems associated with the data and previous modeling efforts. We show that estimates of the strength of the epitope-specific CTL response depend on the method used to fit models to experimental data and on the assumptions made regarding how mutants are generated during infection. We illustrate that allowing CTL responses to decay over time may improve the fit to experimental data and provides higher estimates of the killing efficacy of HIV-specific CTLs. We also propose a novel method for simultaneously estimating the killing efficacy of multiple CTL populations specific for different epitopes of HIV using stochastic simulations. Lastly, we show that current estimates of the efficacy at which HIV-specific CTLs clear virus-infected cells can be improved by more frequent sampling of viral sequences and by combining data on sequence evolution with experimentally measured CTL dynamics.

An Efficient Therapy Strategy under a Novel HIV Model

Evolutionary Game Theoretic Strategy for Optimal Drug Delivery to Influence Selection Pressure in Treatment of HIV-1

Long-term potentiation in rat hippocampus is inhibited by low concentrations of ethanol

Model-free based control of a HIV/AIDS prevention model

Transmission dynamics and optimal control strategies in a multi-pathways delayed HIV infection model with multi-drug therapy

Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses

The contents of the neuro-excitatory amino acid β-ODAP (β-N-oxalyl-l-α,β-diaminopropionic acid), and other free and protein amino acids in the seeds of different genotypes of grass pea (Lathyrus sativus L.).

Dynamics and optimal therapy of a stochastic HTLV‐1 model incorporating Ornstein–Uhlenbeck process

Anti-viral drug treatment along with immune activator IL-2: a control-based mathematical approach for HIV infection

Free Final-Time Optimal Control for HIV Viral Dynamics

Clinical outcomes in hybrid repair procedures for pathologies involving the aortic arch

Piecewise immunosuppressive infection model with viral logistic growth and effector cell-guided therapy

Sliding mode dynamics and optimal control for HIV model

Optimal control strategies to tailor antivirals for acute infectious diseases in the host

A mathematical model for HIV dynamics with multiple infections: implications for immune escape

Optimal control strategies for HIV and COVID-19 co-infection: a cost-effectiveness analysis

Hybrid Spreading Mechanisms and T Cell Activation Shape the Dynamics of HIV-1 Infection

Selective elimination of host cells harboring replication-competent human immunodeficiency virus reservoirs: a promising therapeutic strategy for HIV cure

Modeling optimal control strategies for HIV and gonorrhea co-infection: Incorporating screening along with treatment

Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis

Numerical Optimal Control of HIV Transmission in Octave/MATLAB